ライフサイエンスコーパス: lentigo

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ing sign during the follow-up of extrafacial lentigo.

2 Histological melanocytic changes resembling lentigo and lentigo maligna were seen in several skin gr

3 The management of lentigo maligna (LM) and LM melanoma (LMM) is challengin

4 SEER data revealed lentigo maligna (LM) as the most prevalent in situ subty

5 systematically evaluated for the presence of lentigo maligna (LM) criteria.

6 Lentigo maligna (LM) is a clinical, pathologic, and ther

7 The diagnosis of extrafacial lentigo maligna can be a challenge because the dermoscop

8 n facial lesions and was associated with the lentigo maligna histologic subtype.

9 n AM (44.4%) and occasional amplification in lentigo maligna melanoma (10.5%) and superficial spreadi

10 Worldwide, lentigo maligna melanoma (LMM) comprises 4%-15% of cutan

11 ing basal cell cancer, squamous cell cancer, lentigo maligna melanoma and cutaneous T-cell lymphoma.

12 an axial site, and superficial spreading or lentigo maligna melanoma types (P = .02, P < .001, and P

13 rs, as well as cutaneous T-cell lymphoma and lentigo maligna melanoma.

14 Melanomas classified as lentigo maligna melanomas or as occurring on severely su

15 preading melanomas, 17 nodular melanomas, 19 lentigo maligna melanomas, 18 AMs, and 12 unclassifiable

16 (100%) mucosal melanoma and two of 10 (20%) lentigo maligna melanomas.

17 The pathologic diagnosis of lentigo maligna was established in each case.

18 Lentigo maligna was the most frequent subtype of melanom

19 l melanocytic changes resembling lentigo and lentigo maligna were seen in several skin grafts treated

20 l spreading subtype (nodular, 0.5 [0.2-1.0]; lentigo maligna, 0.4 [0.2-0.7]; and unclassified/other,

21 n into four subtypes: superficial spreading, lentigo maligna, nodular, and acral lentiginous.

22 29.4% vs 8.7%; P < .001) and of the nodular, lentigo maligna, or acral lentiginous histologic subtype

23 Imiquimod leads to an 80-100% cure rate of lentigo maligna; however, studies of invasive melanoma a

24 ficial spreading melanoma and some of facial lentigo maligna; however, these features are often absen

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。